Posted: Sunday, March 28, 2021. 6:33 pm CST.
By Benjamin Flowers: Prensa Latina is reporting that nearly 35,000 people have received Cuba’s Soberana 02 COVID-19 vaccine as a part of Phase III clinical trial.
Finlay Vaccine Institute (IFV) Deputy Director Yuri Valdes informed that 44,010 volunteers are expected to complete the trial on Wednesday, March 31 and that a trial could soon start which sees the vaccine being tested on a population of volunteers below 18 years of age.
The report said that Soberana 02 Phase III trials are aiming to demonstrate the vaccine’s efficacy through two vaccination programs: one with two doses of the shot and a third booster dose with Soberana Plus, also developed by the IFV, will be added.
“In addition to the volunteers who have already received the vaccine in that period, more than 13,000 Cuban health and biopharmaceutical workers were vaccinated this week and included in the intervention trial that started on Monday, March 22, in which 150,000 individuals must be vaccinated,” Prensa Latina noted.
As a routine part of the clinical-epidemiological testing process, volunteers will be exposed to the SARS-CoV-2 coronavirus, the pathogen that causes COVID-19, in real situations of community contagion and the effects of vaccination in population sectors with high risk, disease and spread of the pandemic, to determine the level of protection the vaccine offers.
Аdvеrtіѕе wіth thе most visited news site in Веlіzе ~ Wе оffеr fullу сuѕtоmіzаblе аnd flехіblе dіgіtаl mаrkеtіng расkаgеѕ. Yоur соntеnt іѕ dеlіvеrеd іnѕtаntlу tо thоuѕаndѕ оf uѕеrѕ іn Веlіzе аnd аbrоаd! Соntасt uѕ аt [email protected] оr саll uѕ аt 501-601-0315.
© 2021, BreakingBelizeNews.com. This article is the copyrighted property of Breaking Belize News. Written permission must be obtained before reprint in online or print media. REPRINTING CONTENT WITHOUT PERMISSION AND/OR PAYMENT IS THEFT AND PUNISHABLE BY LAW.